A monoclonal antibody has been prepared against rat angiotensin-converting enzyme (ACE). By selection for antibody binding to endothelial cells of bovine rather than rat origin we have obtained a reagent that has broad cross-species binding properties and that can at the same time serve as a useful marker for the surface of endothelial cells. The IgM-producing clone that we have established, a-ACE 3.1.1, has been grown in ascites form to yield ascites fluid that binds selectively to immobilized ACE at a >1:10,000 dilution. By use of enzyme-linked immunosorbent assays, immunofluorescence histology, and flow cytometry, we have demonstrated the presence of ACE on endothelial cells of murine, bovine, and human origin. By means of a fluorescenceactivated cell sorter (FACS-IV) we have been able to selectively isolate viable endothelial cells from a mixture of endothelial cells and fibroblasts. We believe the antibody will be useful not only for the selection and in vitro cultivation ofendothelial cells but also as a tool for the identification and pharmacological study of ACE.Angiotensin-converting enzyme (ACE), or kininase II, which cleaves the terminal dipeptide from angiotensin I to form vasoactive angiotensin II and which is active as a dipeptidyl hydrolase in its action on bradykinin and other small peptides, serves as a useful marker for the identification ofendothelial cells from capillaries, veins, and arteries (1-4). Because the enzyme is associated with the cell surface (5), antibodies directed against ACE can serve not only to identify endothelial cells but also can mark them for analysis and isolation without loss of viability.Our interest in the growth and development of murine endothelial cells prompted us to generate monoclonal reagents directed at strongly cross-species reactive ACE. Tests carried out with conventionally generated rabbit anti-rat ACE (6) pointed to rat lung ACE as a suitable immunogen; therefore, we used a rat lung ACE preparation to induce an immune response in mice. Spleens from these mice then were fused by hybridization to nonsecreting mouse myeloma cells to permit isolation and characterization of hybrids (hybridomas) that produced monoclonal antibodies to ACE.We now report on the properties of one such hybridomaits cell-specific and enzyme-directed binding properties and its use as a reagent for identifying and isolating murine, bovine, and human endothelial cells.MATERIALS AND METHODS ACE Preparation. ACE was obtained by following the methods of Lanzillo and Fanberg (6, 7). In brief, rat lungs were dissected after lavage, lightly homogenized in 0.02 M potassium phosphate buffer (pH 8.3), and centrifuged (250 x g; 10 min) to remove cells and debris. The supernatant was recentrifuged (54,000 X g; 60 min) and the pellets then were rehomogenized to yield the "crude enzyme preparation." For further purification, sodium deoxycholate was added; this was followed by centrifugation and dialysis, filtration through Whatman no. 1 paper, and fractionation on DEAE-cellulose columns ...